Has Michael Nagel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,813 in general payments to Michael Nagel, MD across 469 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Nagel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Nagel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Nagel, MD

Neurology with Special Qualifications in Child Neurology · Toledo, OHNPI 1912999350

Payments from drug & device makers

$8,813in general payments, 2019–2025

Across 469 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$2K
UCB, Inc.$892
Neurelis, Inc.$774
SK Life Science, Inc.$473
AbbVie$380
Teva Pharmaceuticals USA, Inc.$310
plus $4K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	58	$1,638
UCB, Inc.	47	$892
Neurelis, Inc.	29	$774
SK Life Science, Inc.	21	$473
AbbVie(2 entities)	21	$380
Teva Pharmaceuticals USA, Inc.	20	$310
AstraZeneca(2 entities)	14	$291
Biogen	16	$271
EMD Serono, Inc.	32	$247
Eisai Inc.	15	$246
Piramal Critical Care	15	$232
Aquestive Therapeutics, Inc.	15	$224
Biocodex, Inc.	6	$179
Jazz Pharmaceuticals Inc.	7	$148
Genentech USA, Inc.	8	$148
Novartis	10	$147
Amgen(2 entities)	9	$137
Acadia Pharmaceuticals Inc	9	$127
Catalyst Pharmaceuticals, Inc.	6	$116
Biomarin Pharmaceutical Inc.	1	$113
Lilly USA, LLC	8	$111
Neurocrine Biosciences, Inc.	6	$108
Lundbeck LLC	6	$96
Argenx US, Inc.	5	$94
CSL Behring	5	$88
ITF Therapeutics LLC	3	$68
Sunovion Pharmaceuticals Inc.	6	$65
Supernus Pharmaceuticals, Inc.	5	$62
Kyowa Kirin, Inc.	4	$61
Biohaven Pharmaceutical Holding Company Ltd.	3	$58
Avanir Pharmaceuticals, Inc.	3	$53
NS Pharma, Inc.	3	$53
Amneal Pharmaceuticals LLC	4	$52
Pfizer	3	$49
TG Therapeutics, Inc.	2	$45
Otsuka America Pharmaceutical, Inc.	2	$43
Tersera Therapeutics LLC	2	$40
Tanabe Pharma America, Inc.	3	$40
Sanofi	2	$39
Alnylam Pharmaceuticals Inc.	2	$35
Bristol Myers Squibb	2	$30
Xeris Pharmaceuticals, Inc.	2	$30
Akcea Therapeutics, Inc.	2	$29
Mallinckrodt Enterprises LLC	2	$28
Upsher-smith Laboratories LLC	2	$28
Nevro Corp.	1	$27
PTC Therapeutics, Inc.	2	$26
Sarepta Therapeutics, Inc.	1	$26
Biohaven Pharmaceuticals, Inc.	1	$25
E.r. Squibb & Sons, L.L.C.	2	$25
Merz Pharmaceuticals, LLC	1	$24
Johnson & Johnson	1	$18
Axsome Therapeutics, Inc.	1	$17
Saol Therapeutics Inc.	1	$17
Acorda Therapeutics, Inc	1	$15
Bausch Health US, LLC	1	$15
Aprecia Pharmaceuticals, LLC	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	1	$14
Aucta Pharmaceuticals, Inc.	1	$13
Zogenix Inc.	1	$13

How this compares

$8,813 in reported general payments places this provider in the 60th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio →

Medicare billing

Part B allowed, 2024

$4,679

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Toledo

Lenora LehwaldToledo$17K
Ateeq HaseebToledo$9K
Carla Lopinto-KhouryToledo$1K
Emily DelosreyesColumbus$4.9M
Anne ConnollyColumbus$4.2M
Andrew HersheyCincinnati$2M
Zarife SahenkColumbus$1.5M
Marielle SamahaCincinnati$1.3M
Bruce CohenAkron$1.3M
Cuixia TianCincinnati$1.2M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →